Sec Form 13G Filing - SB INVESTMENT ADVISERS (UK) LTD filing for Zymergen Inc. (ZY) - 2022-02-14

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

Securities and Exchange Commission

Washington, D.C. 20549

 

 

Schedule 13G

(Rule 13d-102)

Information to be Included in Statements Filed Pursuant

to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

Pursuant to § 240.13d-2

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No.     )*

 

 

Zymergen Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

98985X100

(CUSIP Number)

December 31, 2021

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

 

Rule 13d-1(b)

 

 

Rule 13d-1(c)

 

 

Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 98985X100    Schedule 13G    Page 1 of 9

 

  1    

  Names of Reporting Persons

 

  SB Investment Advisers (UK) Limited

  2  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  England and Wales

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5    

  Sole Voting Power

 

  0

   6  

  Shared Voting Power

 

  26,614,219

   7  

  Sole Dispositive Power

 

  0

   8  

  Shared Dispositive Power

 

  26,614,219

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  26,614,219

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  26.0%

12  

  Type of Reporting Person

 

  CO


CUSIP No. 98985X100    Schedule 13G    Page 2 of 9

 

  1    

  Names of Reporting Persons

 

  SoftBank Vision Fund (AIV M1) L.P.

  2  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5    

  Sole Voting Power

 

  0

   6  

  Shared Voting Power

 

  26,614,219

   7  

  Sole Dispositive Power

 

  0

   8  

  Shared Dispositive Power

 

  26,614,219

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  26,614,219

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  26.0%

12  

  Type of Reporting Person

 

  PN


CUSIP No. 98985X100    Schedule 13G    Page 3 of 9

 

  1    

  Names of Reporting Persons

 

  SVF Endurance (Cayman) Limited

  2  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  Cayman Islands

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5    

  Sole Voting Power

 

  0

   6  

  Shared Voting Power

 

  26,614,219

   7  

  Sole Dispositive Power

 

  0

   8  

  Shared Dispositive Power

 

  26,614,219

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  26,614,219

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  26.0%

12  

  Type of Reporting Person

 

  CO

 


CUSIP No. 98985X100    Schedule 13G    Page 4 of 9

 

  1    

  Names of Reporting Persons

 

  SVF Excalibur (Cayman) Limited

  2  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  Cayman Islands

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5    

  Sole Voting Power

 

  0

   6  

  Shared Voting Power

 

  26,614,219

   7  

  Sole Dispositive Power

 

  0

   8  

  Shared Dispositive Power

 

  26,614,219

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  26,614,219

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  26.0%

12  

  Type of Reporting Person

 

  CO

 


CUSIP No. 98985X100    Schedule 13G    Page 5 of 9

 

ITEM 1.

(a) Name of Issuer:

Zymergen Inc. (the “Issuer”).

 

  (b)

Address of Issuer’s Principal Executive Offices:

5980 Horton Street, Suite 105, Emeryville, California 94608

 

ITEM 2.

(a) Name of Person Filing:

Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

SB Investment Advisers (UK) Limited (“SBIA UK”)

SoftBank Vision Fund (AIV M1) L.P. (“AIV M1”)

SVF Endurance (Cayman) Limited

SVF Excalibur (Cayman) Limited

 

  (b)

Address or Principal Business Office:

The address for SBIA UK is 69 Grosvenor Street, London W1K 3JP, United Kingdom. The address for AIV M1 is 251 Little Falls Drive, Wilmington, Delaware 19808. The address for each of SVF Excalibur (Cayman) Limited and SVF Endurance (Cayman) Limited is c/o Walkers, Cayman Corporate Centre, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands.

 

  (c)

Citizenship of each Reporting Person is:

SBIA UK is organized under the laws of England and Wales. AIV M1 is organized under the laws of the State of Delaware. Each of SVF Excalibur (Cayman) Limited and SVF Endurance (Cayman) Limited is organized under the laws of the Cayman Islands.

 

  (d)

Title of Class of Securities:

Common Stock, par value $0.001 per share (“Common Stock”).

 

  (e)

CUSIP Number:

98985X100

 

ITEM 3.

Not applicable.


CUSIP No. 98985X100    Schedule 13G    Page 6 of 9

 

ITEM 4.

Ownership.

(a-c)

The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of December 31, 2021, based upon 102,400,795 shares of Common Stock outstanding as of October 22, 2021, based on the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 15, 2021.

 

Reporting Person   

Amount

beneficially

owned

    

Percent

of class:

    Sole power
to vote or to
direct the
vote:
     Shared power
to vote or to
direct the vote:
    

Sole
power to
dispose or
to direct
the
disposition

of:

    

Shared

power to

dispose or

to direct

the

disposition

of:

 

SB Investment Advisers (UK) Limited

     26,614,219        26.0     0        26,614,219        0        26,614,219  

SoftBank Vision Fund (AIV M1) L.P.

     26,614,219        26.0     0        26,614,219        0        26,614,219  

SVF Endurance (Cayman) Limited

     26,614,219        26.0     0        26,614,219        0        26,614,219  

SVF Excalibur (Cayman) Limited

     26,614,219        26.0     0        26,614,219        0        26,614,219  

SVF Excalibur (Cayman) Limited is the beneficial owner of the shares of Common Stock reported herein. SVF Excalibur (Cayman) Limited is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P.

SBIA UK has been appointed as alternative investment fund manager (“AIFM”) of AIV M1. SBIA UK is authorized and regulated by the UK Financial Conduct Authority and is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of AIV M1’s investments. As a result of these relationships, each of the Reporting Persons may be deemed to share beneficial ownership of the securities reported herein.

 

ITEM 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

 

ITEM 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

 

ITEM 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.


CUSIP No. 98985X100    Schedule 13G    Page 7 of 9

 

ITEM 8.

Identification and Classification of Members of the Group.

Not applicable.

 

ITEM 9.

Notice of Dissolution of Group.

Not applicable.

 

ITEM 10.

Certification.

Not applicable.


CUSIP No. 98985X100    Schedule 13G    Page 8 of 9

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2022

 

SB Investment Advisers (UK) Limited

By:

 

/s/ Spencer Collins

Name:

 

Spencer Collins

Title:

 

General Counsel

 

SoftBank Vision Fund (AIV M1) L.P.
By:   SB Investment Advisers (UK) Limited, its manager
By:   /s/ Spencer Collins
Name:   Spencer Collins
Title:   General Counsel

 

SVF Endurance (Cayman) Limited
By:   /s/ Karen Ellerbe
Name:   Karen Ellerbe
Title:   Director

 

SVF Excalibur (Cayman) Limited
By:   /s/ Karen Ellerbe
Name:   Karen Ellerbe
Title:   Director


CUSIP No. 98985X100    Schedule 13G    Page 9 of 9

 

LIST OF EXHIBITS

 

Exhibit No.

  

Description

99    Joint Filing Agreement.